BlackRock, Inc. 13D and 13G filings for MacroGenics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | MacroGenics, Inc. MGNX |
BlackRock Inc. BLK |
5,405,501 8.600% |
0 (Unchanged) |
Filing |
| 2024-10-22 3:24 pm Sale |
2024-09-30 | 13G | MacroGenics, Inc. MGNX |
BlackRock Inc. BLK |
5,405,501 8.600% |
-734,848 (-11.97%) |
Filing |
| 2024-01-24 2:27 pm Purchase |
2023-12-31 | 13G | MacroGenics, Inc. MGNX |
BlackRock Inc. BLK |
6,140,349 9.900% |
149,844 (+2.50%) |
Filing |
| 2023-01-24 1:56 pm Purchase |
2022-12-31 | 13G | MacroGenics, Inc. MGNX |
BlackRock Inc. BLK |
5,990,505 9.700% |
795,672 (+15.32%) |
Filing |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | MacroGenics, Inc. MGNX |
BlackRock Inc. BLK |
5,194,833 8.500% |
-718,957 (-12.16%) |
Filing |
| 2021-03-09 6:33 pm Purchase |
2021-02-28 | 13G | MacroGenics, Inc. MGNX |
BlackRock Inc. BLK |
5,913,790 10.500% |
808,959 (+15.85%) |
Filing |
| 2021-01-29 5:22 pm Purchase |
2020-12-31 | 13G | MacroGenics, Inc. MGNX |
BlackRock Inc. BLK |
5,104,831 9.100% |
382,294 (+8.10%) |
Filing |